Detalles de la búsqueda
1.
Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials.
Eur Respir J
; 54(3)2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31285303
2.
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.
Clin Rheumatol
; 42(9): 2311-2319, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37209188
3.
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis.
Clin Rheumatol
; 40(4): 1399-1407, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32915347
4.
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis.
Clin Rheumatol
; 39(10): 2989-2998, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32285258
5.
Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations.
BMJ Open
; 10(12): e039473, 2020 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328257
Resultados
1 -
5
de 5
1
Próxima >
>>